Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- PMID: 26246459
- PMCID: PMC4876675
- DOI: 10.2337/dci15-0012
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Abstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
© 2015 by the American Diabetes Association and the American Heart Association, Inc.
Similar articles
-
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5. Circulation. 2015. PMID: 26246173 Free PMC article. Review.
-
[Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].G Ital Cardiol (Rome). 2016 Mar;17(3 Suppl 2):5S-11. doi: 10.1714/2206.23816. G Ital Cardiol (Rome). 2016. PMID: 27030118 Review. Italian.
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. Circulation. 2019. PMID: 30879355 Free PMC article. Review. No abstract available.
-
Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.J Am Heart Assoc. 2017 Jul 3;6(7):e005627. doi: 10.1161/JAHA.117.005627. J Am Heart Assoc. 2017. PMID: 28673901 Free PMC article.
-
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.Circulation. 2022 Mar;145(9):e722-e759. doi: 10.1161/CIR.0000000000001040. Epub 2022 Jan 10. Circulation. 2022. PMID: 35000404 Review.
Cited by
-
Effects of a combination of dyslipidemia and hypertension on the glycemic control of patients with type 2 diabetes mellitus: a cross-sectional study.SAGE Open Med. 2024 Oct 31;12:20503121241265066. doi: 10.1177/20503121241265066. eCollection 2024. SAGE Open Med. 2024. PMID: 39494163 Free PMC article.
-
Brazilian Society of Angiology and Vascular Surgery guidelines on peripheral artery disease.J Vasc Bras. 2024 Oct 28;23:e20230059. doi: 10.1590/1677-5449.202300592. eCollection 2024. J Vasc Bras. 2024. PMID: 39493832 Free PMC article.
-
Time in target range for systolic blood pressure and glucose with cardiovascular disease and all-cause mortality risks.Hypertens Res. 2024 Oct 30. doi: 10.1038/s41440-024-01969-0. Online ahead of print. Hypertens Res. 2024. PMID: 39478190
-
Incidence and risk factors associated with atrioventricular block in the general population: the atherosclerosis risk in communities study and Cardiovascular Health Study.BMC Cardiovasc Disord. 2024 Sep 27;24(1):509. doi: 10.1186/s12872-024-04163-9. BMC Cardiovasc Disord. 2024. PMID: 39327574 Free PMC article.
-
Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.Mol Cell Biochem. 2024 Sep 16. doi: 10.1007/s11010-024-05118-6. Online ahead of print. Mol Cell Biochem. 2024. PMID: 39283562 Review.
References
-
- Go AS, Mozaffarian D, Roger VL, et al. .; American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127:143–152 - PubMed
-
- Diabetes mellitus: a major risk factor for cardiovascular disease: a joint editorial statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association. Circulation 1999;100:1132–1133 - PubMed
-
- Buse JB, Ginsberg HN, Bakris GL, et al. .; American Heart Association; American Diabetes Association . Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115:114–126 - PubMed
-
- American Diabetes Association Standards of medical care in diabetes—2015. Diabetes Care 2015;38(Suppl. 1):S1–S89 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
